Bayer has joined the ranks of pharma multinationals planning major new facility investments in the US, revealing a plan to ...

In the largest venture financing round this week, Varda Space Industries closed a $251 million financing round to help fund ...

Sanofi's long-running R&D alliance with Regeneron has gone up a gear with a partnership – worth up to $8 billion – that spans ...

Novartis has added a T-cell engager (TCE) developed by China's Abogen Biosciences for autoimmune disorders in a deal that ...

Pharmaceutical launch plans are often thoroughly researched, carefully costed, and internally aligned. The problem is that ...

Frontiers Health 2026, strengthening a long-standing collaboration dedicated to advancing conversations around innovation in ...

The Global Benchmark for Efficient Drug Pricing (GLOBE) model aims to introduce the Trump administration's Most Favoured ...

Bayer has looked internally for a new chief medical officer, appointing Dr Christoph Koenen to the position in addition to ...

AZ's $2 billion investment – at $18.36 per share – puts the UK-headquartered company in the driving seat to pair its ...

Eli Lilly's bid to dominate the next generation of weight-loss therapies has been strengthened by data on a new combination ...

The first product from AbbVie's $8.7 billion takeover of Cerevel two years ago – Parkinson's disease therapy tavapadon – has ...

The US regulatory agency has just started a priority review of Imfinzi (durvalumab), in combination with Pfizer and ...